Bausch Health Companies Inc. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Bausch Health Companies Inc. payments for repurchase of equity for the quarter ending 2014-09-30 was $0.00.
- Bausch Health Companies Inc. payments for repurchase of equity for the quarter ending 2014-06-30 was $3.10M.
- Bausch Health Companies Inc. payments for repurchase of equity for the quarter ending 2013-09-30 was $0.00.
- Bausch Health Companies Inc. payments for repurchase of equity for the quarter ending 2013-06-30 was $0.00.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $3.10M 10-Q · filed 2014-08-01 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-10-24 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |